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Abstract
The advent of metagenomics has profoundly revolutionized our way to describe microbial communities and 
discover sequence based biomarkers of health and disease. Similarly to bacteria commensal fungi are an essential 
part of human ecosystems being involved in the normal development of the immune system and for the maintenance 
of healthy tissues and physiological processes. More and more frequently patterns of fungal species are associated 
to immune disorders and increasing evidences are accumulating of the importance to study the co-occurrence of 
fungal flora and its microbial counterpart to understand the cross-talk between opportunistic fungi and the mammalian 
host. Here we critically analyze the studies investigating thefungal communities inhabiting ourbody, addressing at 
what extent the selection of the approaches and the molecular markers used determine the results obtained.
Keywords: Fungi; Metagenomics; Host microbe interaction; 
Pathogenicity; Dysbiosis
Introduction
The advent of metagenomics is clearly demonstrating how we are 
walking holobiomes [1], made of the genes of our genome and those of 
our metagenome [2–6]. This concept implies that the genes governing 
the interaction of the microbiota and the host are key determinants of 
health and disease. Darwinian selection is therefore acting on a complex 
community of organisms interacting at the organismal level to build 
organs, bodies, communities. Deep sequencing allowed to characterize 
in detail these populations, revealing that the human microbiota 
differs radically at different body sites and among individuals [2, 3]. 
Historically microorganisms that colonize us at birth come from our 
mothers’s vaginal tract and breast milk [7–9] . During the development 
of our immune system we are then exposed to microbial communities 
that enter our body through water, food, and the environment where 
we grow adult. The origin of differences between individuals is still 
debated, however, potentially reflecting distinct colonization early in 
life [10], type and availability of nutrients and different dietary regimens 
[11, 12], and different environmental exposures to microorganism 
[13], such as antibiotic use [14]. The history of our encounters with 
microorganims shapes our immunological make-up, but on the 
evolutionary time scale, our immune system has evolved to tolerate 
certain microbes and attack, get rid of others. Nowadays, bacterial 
genomic sequence data have generated novel hypotheses about species 
and community structures underlying human disorders of immune 
origin [15]. The application of microbial ecology concepts is ultimately 
leading to the conclusion that health and disease can be understood 
only understanding how the symbiotic interactions between microbes 
and human organs harmonically integrate [1].
Due to the greater abundance of bacteria over fungi, investigators 
have mostly focused on the prokaryotic component of the microbiota, 
but fungi are increasingly being recognized to have a role in defining 
these communities and interact with our immune system [16]. 
Fungal eukaryotes have been implicated as causative agents of 
diseases such as Inflammatory Bowel Syndrome (IBS)   (Blasto-cystis), 
Inflammatory Bowel Disease (IBD) (fungi), and “leaky gut” syndrome 
(Candida) [16–18]. These diseases, which have become prevalent 
in western populations, are due to complex changes in the microbial 
community. Elucidating community-wide changes, rather than 
presence or absence of specific taxa, will be crucial to understanding 
the cause and potential treatment in these many-faceted poly-microbial 
diseases [19]. 
More and more information on the incidence and diversity of fungi 
in humans are accumulating, and the primary aim of this review is to 
convince you that the current studies are just describing the tip of the 
iceberg. We will geographically describe the body map of our fungal 
communities (Figure 1) stressing the importance to study mycobiota in 
the context of the bacterial counterpart.
Investigating the mycobiota: target and untargeted 
metagenomics
Comprehensive study of the eukaryotic component of the human 
microbiota is just beginning and lags far behind our understanding 
of the bacterial communities. Culture-based methods relied on 
enumerating the cultivable part of mycobiota, not capturing overall 
community structure and its spatial and dynamic properties. And 
reports using NGS suggest diverse fungal communities in humans (as 
described below). High-throughput sequencing technologies made 
metagenomics (i.e the direct sequencing of fungal DNA) the main 
method for characterizing the mycobiota. 
There are two main approaches used in metagenomics, untargeted 
metagenomics and targeted metagenomics [20]. The untargeted 
approach sequences all the DNA content of a sample without 
amplification using mainly the Illumina/Solexa sequencing platforms 
[21]. The principle is the sequencing-by-synthesis technology, but it 
is based on the use of reversible terminator nucleotides labelled with 
a different fluorescent dye depending on the type of nucleotide [22]. 
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The most recent advancements in ecological metagenomics are indeed 
going to use untargeted approaches sequencing the entire DNA content 
of a sample, the actual utility of these futuristic approaches, already of 
common use for human metagenomics, largely depends on the number 
of sequenced and annotated genomes of environmental microbes, 
an aspect that currently provides the greatest challenge for the wider 
scientific community working on environmental microbiology [23]. 
Application of untargeted methods to investigate fungal communities 
is extremely difficult since the relative abundance of bacterial cells 
reduces the overall number of eukaryotic or fungal reads. 
The targeted approaches uses the sequence of molecular clock 
genes to infer the phylogenetic structure of the microbial community. 
Predominant among the targeted approaches, is ribosomal RNA, rRNA 
phylotyping [24]. The success of this technique is based on the enormous 
database of rRNA gene sequences (more than 200,000) that have been 
collected for reconstructing the universal Tree of Life [25]. Targeted 
approaches are currently the method of choice for the investigation 
of fungal populations. The most sensitive and affordable approach 
for fungal targeted metagenomics is to sequence a small variable 
region of fungal genomes like internal transcribed spacer regions, 18S 
small-subunit ribosomal DNA (rDNA), 28S large-subunit rDNA. The 
ribosomes of eukaryotic organisms are composed of two structural 
Figure 1:  Different human body sites are dominated by different fungal genera. 
In the picture, the main fungal genera dominating the specific body sites are indicated. With the exception of S. cerevisiae, images are of courtesy of www.doctorfungus.
org © 2007.
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subunits, 60S and 40S. The 60S subunit contain three different types 
of rRNA fragments: 28S, 5.8S and 5S rRNA. The 40S has a single 18S 
RNA fragment. The genes coding for the different fragments of rRNA 
are repeated genes, constituting the nucleolus organize region (NOR). 
Within the chromosome are clustered into structural units separated 
by non-coding spacer sequences called NTS (non-transcribed spacer) 
and IGS (intergenic spacer). Each unit consists of a structural and 
external transcribed spacer (ETS), located at the 3 ‘end of the 18S gene, 
two internal transcribed spacers (ITS), situated respectively: the ITS1 
between the gene 18S and 5.8 S gene, the ITS2 between the 5.8S 3 ‘end and 
the 28S gene and 5S gene is separated from the 28S gene from another 
non-coding spacer sequence. ITS1 region, such V3-V5 region of the 
16S, are hypervariable regions, so their sequencing allows us to identify 
fungi at the species or genus level, and in the case of a metagenomic 
analysis, to understand the composition of the fungal communities 
present in a particular habitat. In a number of studies the co-sequencing 
of fungal 18S rDNA/ITS and bacterial 16S rDNA sequences resulted the 
optimal method for the investigation of the biodiversity and function of 
the global microbiota which exists in each part of the human body  [26, 
27]. Recently co-sequencing of 18S rDNA and ITS has been proposed 
as more suitable for fungal classification. Indeed the results’ quality 
depends on having a comprehensive, well-annotated database of fungal 
sequences with which to compare the sequencing data. Whereas several 
excellent databases have been developed for identifying bacterial 16S 
rDNA sequences, fungal sequences databases are still in their infancy, 
where less than 1% of fungal species are currently represented [28]. 
Analyzing NGS data requires even more new computational tools, 
such as co-occurrence networks, protein-protein interactome [29] and 
pipelines for comparing large numbers of samples, enabling, in the 
next future, the patterns in these data to be elucidated. Furthermore, 
fungal taxonomy is currently improving as fast as the different fungi are 
characterized. Sequencing and annotating much more fungal genomes 
is required to properly delve into the biology and the interactions that 
make the complexity of their population and community structure. 
How changes in the fungal and bacterial community structure leads 
to health or disease can be understood only in the context of the 
evolutionary forces shaping their adaptation to the host. 
Despite the existing limitations the initial application of 
metagenomics to fungal communities has produced in the past three 
years more information of that obtained in the previous thirty. The 
information summarized in Figure 1 is indeed going to rapidly evolve 
with the exponential increase of community level genome-wide surveys 
of the microorganisms inhabiting the various microenvironments of 
the human body (i.e. gut, skin, oral mucosa and urogenital tract), their 
environmental reservoir, and the human populations living in different 
geographic regions.
The host and its double: being a commensal or a pathogen is 
a matter of dysbiosis
Pathogens are typically considered as discrete causative agents 
in virulence studies, even if they exist within a rich milieu of other 
microbial species, as well as host factor, that can influence pathogenicity. 
Thus, disease could derive from dysbiosis of the microbial community 
that refers to a condition with microbial imbalances on or inside the 
body. This paradigm requires that diseases of microbial origin must 
be investigated within the context of their microbial community, host 
factors and immunity. Genome-wide surveys of the microorganisms 
inhabiting the different microenvironments of the human body (i.e gut, 
skin, oral mucosa and urogenital tract) [30], soil [31], and population 
living in different geographic regions [12, 13] have suggested the 
presence of strong selective control on the microbial communities 
that can colonize and persist in particular environments. Thus, 
understanding the prevalence and distribution of microbial eukaryotes, 
in addition to prokaryotic microorganisms, in the human body, may 
have large consequences for human health.
While the focus is generally, in terms of study effort, genome 
sequencing, etc., on pathogens or conditional pathogens (i.e. their 
pathogenic potential is unleashed upon failure from the immune system 
to keep them at bay), most microbial resident eukaryotes do not cause 
infections, being either beneficial or commensal. Commensal microbes 
significantly shape mammalian immunity, both at the host mucosal 
surface and systemically [32], controlling unexpected microbial burden 
and growth. 
However, fungi belonging to commensal genera such as Candida 
and Malassezia show a clear potential to infect the host when they 
become abundant or infect immunocompromised subjects. 
At mucosal surfaces, those opportunistic fungi are controlled 
by the normal microbial flora, the epithelium and its innate immune 
system: this tight control allows to refer to them as part of the normal 
mycobiota. Although the commensal stage is frequently reported as 
inoffensive to the host, it is likely that this stage is highly regulated by 
a continuous or transient cross-talk between the fungus and the host 
immune system [33]. The latter maintains homeostasis with resident 
microbial populations, ensuring the balance between tolerogenic 
and pro-inflammatory response. In parallel, commensal microbes 
significantly shape mammalian immunity both at the host mucosal 
surface and systemically [33, 34] controlling un-expected microbial 
burden and growth. 
Mucosal fungi modulate both the innate and adaptive immune 
responses. C. albicans is able to train the innate immunity towards other 
microorganisms, such as intestinal and skin bacteria [34–36]. Even S. 
cerevisiae, which presence was recently reported in the human skin [16, 
27, 37, 38]  and in the gut microbiota (De Filippo et al., submitted) 
educates the host immune response to better cope a secondary infection 
(Rizzetto et al., submitted). 
Indeed, the configuration of the commensal microbiota is being 
newly appreciated as complex and important for health, with increasing 
evidences suggesting a novel perspective on the role of non-pathogenic 
fungi in contributing to a correct immune homeostasis [39–41].
An increased understanding of the importance of microbiota 
in shaping the host’s immune and metabolic activities has rendered 
fungal interactions with their hosts more complex than previously 
appreciated. It is now clear that a three-way interaction between 
host, fungi, and microbiota drives the host-fungus relationship. The 
aryl hydrocarbon receptor (AhR) has a pivotal role in driving this 
connection linking tryptophan catabolism by microbial communities 
and the host’s own pathway of tryptophan metabolite production. 
Its activation by the commensal microbial community, it plays an 
antimicrobial role and an anti-inflammatory role - mediating the 
differentiation of regulatory T cells [42]. In addition to the evidence 
that via AhR activation Lactobacillus reuteri, contributes to mucosal 
resistance against the opportunistic pathogen Candida. albicans [43], 
an increased concentration of AhR ligands in the skin has been linked 
to the development of Malassezia-associated skin diseases [44, 45].
Indeed, microbial dysbiosis predisposes either causally or 
consequently to a variety of diseases including cystic fibrosis CF [46], 
inflammatory bowel disease (IBD) [47], atopic dermatitis [48], and 
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chronic mucocutaneous candidiasis (CMC) [49]. However, it has 
been unclear whether this variation is primary or secondary to an 
imbalanced bacterial microbiota. 
Physical and quorum sensing interactions occur between fungi 
and bacteria. Those interactions can be antagonistic, synergistic, 
commensal or symbiotic and influence physical and physiological 
characteristics such as the mutual morphology, behavior and survival 
including response to anti-microbial agents [50]. It has been shown that 
in the mouse gastro-intestinal gut, commensal fungi co-exists in the 
same patches with bacteria [51]. Quorum-sensing molecules are often 
the basis of the interaction between fungi and bacteria. For example, 
C. albicans can inhibit the virulence of P. aeruginosa through farnesol, 
while P. aeruginosa can affect the growth, morphology and virulence 
of C. albicans through the virulence factors pyocyanin and phenazines 
[52–54].
Moreover, germ-free mice are highly susceptible to Candida infection 
[55], and antibiotic treatment supports colonization by and robust 
expansion of fungal species in the mouse gut [56–58], reaching the 99% 
of the total intestinal microorganisms [58]. This was mostly due to an 
expansion of Candida species, which was the only genus that was found, 
by deep sequencing, in the feces. The same occurs in humans: prolonged 
antibiotic treatment predispose to Candida infections [59, 60]. 
Moreover, a recent study has demonstrated that after a broad 
spectrum antibiotic treatment with cefoperazone, the colonization with 
C. albicans strongly altered the restoration of the bacterial communities 
after treatment [61]. The presence of the fungus shifts the bacterial 
proportion: Bacteriodetes and Lactobacillaceae decrease in size, while 
Firmicutes populations remained unchanged.
Collectively, the eukaryotic and prokaryotic communities are 
kept in equilibrium by mutual interactions that include production of 
immune modulating molecules, helping to accommodate fungi, either 
commensals or ubiquitous, within the immune homeostasis and its 
dysregulation. Building a large database of co-occurring eukaryotic 
and bacterial communities will allow one to test the hypothesis that 
changes in the bacterial community are responsible for the variance in 
the pathogenicity of eukaryotic microorganisms or vice versa.
Fungi inhabiting the skin surfaces
The skin represents the primary interface between the host and the 
environment. Deep sequencing approaches have demonstrated that 
the healthy skin contains a unique bacterial and fungal microbiota [30, 
38, 62–64]. The composition of this microbial community depends on 
physiologic attributes and topography of the skin, with certain patterns 
being associated with moist, dry or sebaceous microenvironments [30, 
62]. Culture-dependent approaches have identified many commensal 
fungi that are present on the skin, with Malassezia as the most common 
genus, followed by Penicillium and Aspergillus [38, 62, 65]. Other 
fungi, such as Alternaria, Candida, Rhodotorula and Cladosporium, 
have also been cultured but with a lower frequency [38, 64, 65]. 
Culture-independent sequencing studies have confirmed that the 
genus Malassezia is most commonly represented on healthy human 
skin across different body sites [38, 48, 66]. Eleven body sites were 
found to be dominated by Malassezia fungi but by contrast [38], foot 
sites (plantar heel, toe nail, and toe web) exhibited the greatest fungal 
diversity (40-80 genera), with the presence of a wide range of fungal 
genera (i.e Rhodoturola, Debaromyces, Cryptococcus, and Candida), 
of which Candida species  were mostly represented by C. tropicalis, 
C. parapsilosis and C. orthopsilosis. Changes in the fungal microbiota 
of the scalp that accompany dandruff have been also examined [67]. 
While fungi of the Ascomycota dominated in both healthy and 
dandruff patients, fungi of the Basidiomycota phyla (which includes 
Malassezia) were significantly increased in dandruff-afflicted scalps. 
Specific genera that were increased in patients with severe dandruff 
included Filobasidium, which jumped to 94% of the total basiomycetes, 
and Malassezia (5%), which represents a twofold increase over healthy 
samples. By contrast, healthy scalps were dominated by basiomycete 
fungi of the genus Cryptococcus [67].
Cutaneous inflammatory disorders such as psoriasis, atopic 
dermatitis (AD), and rosacea have been associated with dysbiosis in the 
cutaneous microbiota [68–71].
To characterize that dysbiosis, Zhang and coworkers used an rRNA 
gene clone library of 3647 clones to identify 58 fungal species and 7 
unknown phylotypes from AD patients and healthy individuals [48]. As 
expected, Malassezia species were predominant, accounting for 63–86% 
of the clones identified from each subject. Overall, AD patients showed 
an increase diversity of the non-Malassezia yeast communities with 
respect to healthy subjects. C. albicans, C. diffluens, and C. liquefaciens 
as well as the filamentous fungi Cladosporiumn gi spp. and Toxico 
cladosporium irritans were detected in AD samples but were seldom 
detected in healthy samples [48]. 
An exemplary recent publication [36] has added another 
fundamental contribution to the role of skin microbiota in activating and 
educating host immunity, shedding new light on the interplay between 
the immune system and microbiota. The authors studied patients 
with hyper IgE syndrome, a primary immunodeficiency disease (PID) 
due to STAT3 deficiency, and compared the bacterial and fungal skin 
microbiota at four clinically relevant sites representing the major skin 
microenvironments [36]. The patients exhibited increased ecological 
permissiveness, characterized by an altered bacterial community 
(showing  a colonization with Clostridium spp and Serratia marcescens) 
and an increased fungal diversity with augmented abundance of 
Candida and Aspergillus species. This increased representation of 
opportunistic fungi was concomitant with a decrease in the relative 
abundance of the common skin fungus Malassezia [36].
Analyses of the co-occurrence of specific bacteria and fungi 
have suggested that the two communities might interact in the skin 
mucosal surface. The intra-kingdom interaction seems to occur with 
Malassezia globosa and most genera of Firmicutes and Actinobacteria 
in both controls and STAT3-HIES patients with a correlated reduction 
of Malassezia restricta. In patients’ group, streptococci, coryneforms, 
and S. aureus were uniquely correlated with the presence of Candida, 
Aspergillus and Cryptococcus.  
The skin microbiota investigation provides an important step toward 
understanding the interactions between pathogenic and commensal 
fungal and bacterial communities, and how these interactions can 
result in beneficial or detrimental (i.e., disease) outcomes. 
Fungi inhabiting the oral mucosa
The oral microbiota is a critical component of health and disease. 
Disruption of this community has been proposed to trigger or influence 
the course of oral diseases, especially among immunocompromised 
patients [72]. Metagenomic sampling of individual sites within the oral 
cavity shows that there are probably hundreds of different microbial 
niches [73–76]. The fungal component of the oral microbiota, however, 
has been only recently characterized. The most comprehensive study 
to date on the fungal microbiota of healthy mouth found that the 
distribution of fungal species in the mouth varied greatly between 
different individuals. This multi-tag pyrosequencing approach showed 
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that the oral cavity hosts to >75 different fungal genera with Candida, 
Cladosporium, Aureobasidium, Saccharomycetales, Aspergillus and 
Fusarium being among the most common [27]. The remaining 60 
nonpathogenic fungi detected in the oral wash samples represent 
species that likely originate from the environment in the form of spores 
inhaled from the air, or from material ingested with food. Thus, the 
presence of these microbes in the oral cavities of healthy individuals 
was not necessarily surprising, but the observation that transient 
colonization by environmental fungi may occur in the oral cavity (and 
upper airways) has potential implications for hypersensitivity diseases. 
Using a different approach based on high-throughput sequencing 
analysis of ITS1 variable region, a subsequent study reported that 
Malassezia spp. and Epicoccum are also abundant [77] in the saliva of 
healthy subjects. 
The presence of pathogenic fungal isolates in the oral cavity of 
healthy individuals is quite unexpected and the clinical relevance 
is unknown. It is possible that the presence of a given fungal isolate 
in an individual could be the first step toward predisposing that 
individual to opportunistic infections. The pathogenicity of the fungi 
in the oral environment may be controlled in healthy individuals by 
other fungi or other member of the oral community, as well as by the 
functional immune system, suggesting that interdependent cross-talk 
may exist between constituents of the oral mycobiota. Surveying the 
oral microbiota of 12 HIV-infected patients and 12 healthy subjects 
showed that the core oral bacterial microbiota comprised 14 genera, 
of which 13 were common between patients and healthy subjects [78]. 
In contrast, the core oral mycobiota differed between HIV-infected and 
uninfected individuals, with Candida being the predominant species 
in immunocompromised patients. Increase in Candida colonization, 
particularly C. albicans, was associated with a concomitant decrease 
in the abundance of Pichia - a resident oral fungus, suggesting an 
antagonistic relationship. Indeed, Pichia inhibits growth of pathogenic 
fungi; such as Aspergillus and Candida by inhibit the ability to adhere, 
germinate, and form biofilms [78]. 
Oral Candida colonization is a known risk factor for invasive 
Candidiosis [79]. Similarly, periodontal disease is associated with 
rheumatoid arthritis [80] and atherosclerosis [81], suggesting that 
bacterial and fungal microbiota from the oral cavity may contribute to 
the development of certain human diseases. According to that, Candida 
albicans and Streptococcus spp. can form a mixed biofilm with anti-
microbial antagonism by a complement of adhesin-receptor interactions 
involving two families of streptococcal multifunctional polypeptide 
adhesins and bacterial cell wall polysaccharide [82, 83]. This physical 
interaction results in a synergistic increase of their invasiveness in the 
oral and upper gastro-intestinal tract mucosa in vivo [82].
Fungi inhabiting the lung mucosa
Although the lungs are constantly exposed to oral and environmental 
fungi [84], the lower respiratory tract (trachea, bronchi and pulmonary 
tissue) was thought to be sterile when healthy. 
However, if the respiratory tract epithelium becomes damaged, 
as in bronchitis or viral pneumonia, the individual may become 
susceptible to infection by pathogens, such as Aspergillus, descending 
from the nasopharynx (upper respiratory tract). The normal bacterial 
part of microbiota has been addressed more deeply than its fungal 
counterpart. It consists of 9 core genera: Prevotella, Sphingomonas, 
Pseudomonas, Acinetobacter, Fusobacterium, Megasphaera, Veillonella, 
Staphylococcus, and Streptococcus [85, 86] but few data exist about the 
fungal microbiota of the lungs, with the exception of Pneumocystis spp. 
In a recent study by Charlson and collegues, the fungal microbiota of 
the mouth and lungs in select healthy and lung transplant recipients 
was analyzed by ITS-based pyrosequencing [87]. The patients’ fungal 
microbiota of the oral cavity was dominated by Candida, while 
bronchoalveolar lavage showed detectable Candida spp., Aspergillus 
spp., or Cryptococcus spp. This mycobiota composition likely depends 
on the antibiotic and immunosuppressant use supporting the notion 
that heathy host defense, and perhaps some complex interplay between 
lung-colonizing microbial communities and invading pathogens, play 
a major role in keeping fungal colonization extremely low in the lungs.
Cystic fibrosis (CF) provides an important example of the need to 
enhance our knowledge of the composition of the microbial community 
in order to improve management of patients susceptible to pulmonary 
infections. Using ITS2 and 16 rRNA pyrosequencing, Delhaes and 
coworkers [46] extensively explored the diversity and dynamics of 
fungal and prokaryotic populations in the lower airways of CF patients. 
The authors identified 30 genera, including 24 micromycetes, such as 
Pneumocystis jirovecii or Malassezia spp, and 6 basidiomycetous fungi. 
Among the organisms identified, filamentous fungi belonging to the 
genera Aspergillus and Penicillium had previously been suggested as 
pathogens in CF patients [88]. C. albicans and C. parapsilosis were also 
recently described as colonizer organisms of CF patients [89, 90]. 
CF microbiota was characterize by a large proportion of anerobes 
and in particular by Pseudomonas aeruginosa, which was more likely to 
be observed in association with Candida. albicans than with Aspergillus. 
fumigatus [46]. This can be explained by the fact that colonization of C. 
albicans in rat lungs prior to Pseudomonas spp. exposure may increase 
the incidence of Pseudomonas-related pneumonia, because C. albicans 
can impair the local host immune response by inhibiting reactive 
oxygen species production by alveolar macrophages [91]. 
Keeping in mind the co-occurrence of the microbial communities 
transiently or persistently colonizing the lung [92, 93], a modification 
in lung mycobiota may result from a primary dysbiosis of bacteria. 
Indeed, the causative or the correlative relation between changes in 
lung mycobiota and disease onset needs to be proven by expanding the 
number of samples and moving forward the study from the species to 
the strain level.
Fungi inhabiting the vaginal mucosa
Vagina hosts a set of microbial occupants that, if not properly 
contained, can cause pathologies. While yeast infections are common, 
epidemiological and mycobiome studies reveal a more diverse 
population of resident fungi than has been previously appreciated [94–
97] . These studies indicate the presence of 11–20 different genera, with 
commonly detected fungi including Candida (C. albicans, C. glabrata, 
C.parapsilosis, C. tropicalis, and C. krusei), Saccharomyces, Aspergillus, 
Alternaria and Cladosporium.  Changes in fungal diversity were found 
to be associated with immuno deficiencies [97], diabetes [95], allergic 
rhinitis [96] and recurrent vaginal candidiasis[96]. Fungal growth 
is controlled both by host immune system and the competition with 
the local bacterial communities. Lactobacilli species are the dominant 
microorganisms in the healthy vaginal microbiota [98], which lactic 
acid production helps in maintaining an acid environment thus 
impeding fungal growth [99, 100].
Fungi inhabiting the gut
The human gastrointestinal tract is known to contain a variable 
fungal microbiota, but the phylogenetic characteristics of those fungal 
microorganisms and their specific roles as part of the gastrointestinal 
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tract (GI) ecosystem have not yet been studied extensively. Whereas 
initial cultured dependent surveys only suggested that human and 
mouse GI are populated by diverse fungal microbiota, more recently, 
high-throughput sequencing approaches have been used to in depth 
and quantitatively explore the fungal communities that populate both 
the human and mouse gut. These studies have shown that the gut host 
up to 50 genera of fungi with Candida, Saccharomyces and Cladosporium 
species being particularly common [51, 101].  An example of the large 
variability of the human gut mycobiota was provided by a study of four 
children and their respective mothers, which reported that infants 
harbor Saccharomyces spp. as opposed to Candida as the most frequent 
fungal species (36%) [102]. A recent study conducted on Wayampi 
Amerindian community, showed a high diversity among yeast species, 
with a prevalence of S. cerevisiae over Candida species [37], suggesting 
a role for this fungus in gut immune homeostasis.
Whether S. cerevisiae is present at birth remains to be elucidated. 
It is possible that yeasts simply reach the gastrointestinal tract through 
food. Alternatively, it is possible that differences in fungal colonization 
are related to differences in the genetic makeup of the host or 
differences in gut permeability. A few studies have been conducted to 
examine fungal community dysbiosis in chronic disease, including IBD 
[16, 51]. Studies of the mycobiota in a murine model of induced colitis 
highlighted the importance of gut fungal communities in contributing 
to the boost in intestinal inflammation seen upon DSS treatment [51], 
with a marked increase in the abundance of C. tropicalis observed 
during active colitis. These studies are the first steps toward clarifying 
the role of the gut mycobiota in intestinal inflammation, and may 
help explain the increased serum levels of anti-S. cerevisiae antibodies 
(ASCA) in CD patients [103]. 
A more recent study on 19 patients suffering from active Crohn’s 
disease CD investigating the mucosa-associated and fecal fungal 
microbiota showed that the fungal richness and diversity were higher 
in the inflamed mucosa compared with the non-inflamed mucosa. 
The predominant fungal composition of CD mucosa and feces are 
being characterized by expansion in the proportions of Candida spp., 
Gibberella moniliformis, Alternaria brassicicola, and Cryptococcus 
neoformans,Aspergillus. clavatus, and C. neoformans. The species 
richness and diversity of the mucosal fungal community were associated 
with the expression of TNFα, IFNγ, or IL-10 and positively correlated 
with serum C-reactive protein and CD activity index [47]. Whether 
changes in gut fungal microbiota are the cause or the consequence of 
mucosal inflammation and disease activity of CD remains yet to be 
understood. Additionally fungal role in health and disease could be 
that of favoring growth of certain bacterial species and limiting the 
growth of others. Lactobacillus spp. and C. albicans have antagonistic 
relationship inside the gut. Even if not able to completely eradicate C. 
albicans, the bacterium could inhibit the growth and virulence of C. 
albicans by the production of hydrogen peroxide and organic acids 
[104, 105]. Moreover, commensal Lactobacilli produce the metabolite 
indole-3-aldeyde (IAld) by tryptophan metabolism, activating the 
Ahr mediated IL-22 response which in turns reduces colonization 
by C. albicans [43]. Indeed, Lactobacilli provide local protection and 
resistance to fungal infection. 
Several reports suggest that diet is a main driver of gut fungal 
diversity. Studies in newborn mice and in human infants have suggested 
that bacterial communities in the gut are initially unstable but become 
more stable in early childhood and develop more modestly throughout 
adulthood [106, 107]. However, this may not be the case with the gut 
mycobiota. One recent study demonstrated that fungal populations 
in the mouse gut displayed episodic variation over several months, 
although the bacterial community remained relatively stable [58]. 
This suggests that commensal fungal populations are more variable 
than those of bacteria and that they may be influenced by fungi in the 
environment. Diet is a constant and dynamic factor shaping mucosal 
immunity as well as the composition of resident microbial populations 
in the gut. Hoffmann et al. investigated the association of diet with 
fungal populations, analyzing 98 fecal samples [101]. Deep sequencing 
revealed 62 fungal genera and 184 species with generally mutually 
exclusive presence of either the phyla Ascomycota or Basiodiomycota. 
Moreover, the consumption of a plant based diet has been linked to 
an increase in gut colonization by Candida species, whereas the 
consumption of an animal-based diet facilitated the expansion of 
Penicillium species [11].
Thus, integrating information on the repertoire of the gut mycobiota 
in the context of the broader microbiota and developing functional tests 
to measure its role in shaping immune function is necessary to better 
understand the role of the microbial communities in sustaining human 
health. The development of a highly specialized symbiosis requires 
iterative sets of mutual adaptation between and among commensal 
microorganisms and their hosts. This requests integrating the microbial 
diversity surveys with the identification of  specific metabolites that cab 
directly target the diverse immune function (i.e the IDO1- AhR axis) 
for the promotion of infection, its control and immune resistance.
Conclusions 
Recent culture-independent surveys of eukaryotic communities 
reveal that, similar to bacteria, commensal fungi are an essential part 
of human ecosystems. Fundamental research on fungal communities 
of the human host will have to understand the role of diet and 
environmental changes in exposure to fungi. Globalization has meant 
diet standardization and elimination of microorganisms from food 
products, as well as an increased use of antibiotics. Both these factors 
are shown to alter significantly the bacterial composition of the 
gut microbiota of children living in the globalized world [12].  How 
globalization affects our exposure to dietary and environmental fungi is 
one of the most interesting paths of research yet to be explored.
The role of the mycobiota in the maintenance of health can only be 
understood only using a “systems level” integrated ecological approach, 
as opposed to an approach focused on specific, disease-causing taxa. 
Commensal fungal populations vary between body sites, vary over time 
and with disease, specifically interacting with the immune system. The 
molecular and cellular mechanisms that engage specific fungi during 
steady-state healthy conditions may be quite different from those that 
are engaged in diseased tissue or during active fungal invasion. Keeping 
in mind the ability of fungi to evade the immune system by subverting 
the host defense i.e by morphological and phenotypic transition it 
will be critical in the next future the need to functionally analyze the 
mycobiota at the strain level in its cross-talk with the immune cells 
and the bacterial counterpart, rather than simply counting its parts at 
the species level. This analysis will require developing strains specific 
markers as well as gaining an understanding of their population and 
community structures in the context of the evolutionary forces shaping 
their adaptation to the different body sites. Studying the role of fungi 
in contributing to immune homeostasis is indeed one of the major 
future challenges we face. Understanding this role could suggest how 
we could preserve the appropriate level of interaction between our 
immune system and fungi, and how this could help us developing 
fungal probiotics or maintaining the right balance between the right 
fungi and the right bacteria, to maintain a healthy immune function. 
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Future studies like in-depth sequencing of the meta-transcriptome 
of eukaryotes, during the interaction with the host immune system, will 
soon help in understanding host-microbes interaction and in exploiting 
this knowledge to prevent or treat fungal and inflammatory diseases.
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